SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-06-016999
Filing Date
2006-04-27
Accepted
2006-04-27 12:16:37
Documents
2
Effectiveness Date
2006-04-27

Document Format Files

Seq Description Document Type Size
1 v041440_defr-14a.htm DEFR14A 692549
2 GRAPHIC stock_graph.jpg GRAPHIC 53357
  Complete submission text file 0001144204-06-016999.txt   767650
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-25169 | Film No.: 06783953
SIC: 2834 Pharmaceutical Preparations